PROTAC TEAD1/IAP degrader-3
PROTAC TEAD1/IAP degrader-3 is a TEAD1/IAP PROTAC degrader. PROTAC TEAD1/IAP degrader-3 recruits the cIAP1 and XIAP E3 ligases to form a ternary complex, drives proteasomal degradation of TEAD1, and triggers autoubiquitination and proteasomal degradation of cIAP1. PROTAC TEAD1/IAP degrader-3 inhibits cell proliferation. PROTAC TEAD1/IAP degrader-3 regulates Hippo pathway activity by downregulating CTGF gene expression in a TEAD-dependent manner. PROTAC TEAD1/IAP degrader-3 is applicable to the research of mesothelioma.
(Pink: TEAD1 ligand (HY-181592); Blue: IAP ligand (HY-181591); Black: linker).
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C47H50F4N6O6
- Peso molecular:870.93
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas PROTACs
MoreVer todos los productos específicos de isoformas YAP
More
Actividad biológica
|
cIAP1 |
TEAD1 |
PROTAC TEAD1/IAP degrader-3 (A538) (0.0001-10 μM; 20 h) induces proteasome-dependent degradation of TEAD1 in NCI-H2052 cells, with a DC50 of 44 nM and a maximum degradation rate of 42%. The degradation depends on cIAP1 and XIAP, where XIAP contributes to achieving the maximum degradation efficacy, while cIAP1 helps enhance the activity of the degrader[1].
PROTAC TEAD1/IAP degrader-3 (0.001-10 μM; 20 h) induces partial degradation of TEAD1 in NCI-H226 cells, with a DC50 of 76 nM and a maximum degradation rate of 38%[1].
PROTAC TEAD1/IAP degrader-3 (0.0001-30 μM; 4 h) forms a stable ternary complex with cIAP1, XIAP and TEAD1 in NCI-H2052 cells[1].
PROTAC TEAD1/IAP degrader-3 (0.5 μM; 16 h) specifically downregulates TEAD1 at the proteome level in NCI-H2052 cells, with no significant effects on other TEAD paralogs[1].
PROTAC TEAD1/IAP degrader-3 (1 nM-10 μM; 144 h) inhibits the proliferation of ZL55, NCI-H2052 and NCI-H226 cell lines[1].
PROTAC TEAD1/IAP degrader-3 (0.001-10 μM; 48 h) modulates Hippo pathway activity in ZL55, NCI-H2052 and NCI-H226 cells via TEAD-dependent downregulation of CTGF gene expression[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:NCI-H2052 cells (stably expressing HiBiT-TEAD1; wildtype)
-
Concentration:0, 0.0001,0.001, 0.01, 0.03, 0.1, 0.3, 1, 3, 10 M
-
Incubation Time:20 h
-
Result:Achieved 48% degradation of endogenous TEAD1 at 3 μM treatment.
Induced HiBiT-TEAD1 degradation with a Dmax of 49% and a DC50 of 293 nM.
Degraded endogenous TEAD1 with a Dmax of 42% and a DC50 of 44 nM.
-
Cell Line:NCI-H226 cells
-
Concentration:0.001-10 μM
-
Incubation Time:20 h
-
Result:Degraded endogenous TEAD1 with a Dmax of 38% and a DC50 of 76 nM.
-
Cell Line:NCI-H2052 cells
-
Concentration:3 μM; 5 μM (MG132)
-
Incubation Time:16 h
-
Result:Completely abolished TEAD1 degradation induced by 3 μM PROTAC TEAD1/IAP degrader-3 (A538), with near 100% recovery of TEAD1 levels, in the presence of MG132.
-
Cell Line:NCI-H2052 wildtype, cIAP1 KO, XIAP KO, and cIAP1/XIAP DKO cell lines
-
Concentration:0.0001, 0.001, 0.01, 0.1, 1, 10 μM
-
Incubation Time:20 h
-
Result:Induced TEAD1 degradation in wildtype cells with a Dmax of 48% and a DC50 of 64 nM.
Reduced Dmax to 27% with a DC50 of 61 nM in XIAP KO cells.
Right-shifted DC50 to 340 nM with a Dmax of 44% in cIAP1 KO cells.
Achieved a Dmax of 28% with a DC50 of 220 nM in cIAP1/XIAP DKO cells.
-
Cell Line:NCI-H2052 cells; NCI-H226 transgenic cell lines (stably expressing HiBiT-TEAD1-4)
-
Concentration:0.0001, 0.001, 0.01, 0.1, 1, 10 μM (endogenous assay); 0.3 nM-10 μM (HiBiT assay)
-
Incubation Time:20 h (endogenous assay); 18 h (HiBiT assay)
-
Result:Degraded TEAD4 with a Dmax of 9% and a DC50 of 510 nM in NCI-H2052 cells, compared to TEAD1 Dmax of 42% and DC50 of 44 nM.
Induced degradation of TEAD1 with a Dmax of ~40%, TEAD2 with a Dmax of <5%, TEAD3 with a Dmax of 13%, and TEAD4 with a Dmax of <5% in NCI-H226 HiBiT assays.
-
Cell Line:ZL55, NCI-H226, NCI-H2052 (mesothelioma cell lines); NCI-H520 (Hippo pathway-independent cell line)
-
Concentration:1 nM-10 μM
-
Incubation Time:144 h
-
Result:Inhibited proliferation in ZL55 cells with an IC50 of 925 nM and an Emax of 100%.
Inhibited proliferation in NCI-H226 cells with an IC50 of 733 nM and an Emax of 100%.
Inhibited proliferation in NCI-H2052 cells with an IC50 of 1267 nM and an Emax of 99%.
Inhibited proliferation in NCI-H520 cells with an IC50 of 443 nM and an Emax of 96%.
-
Cell Line:ZL55, NCI-H226, NCI-H2052 (mesothelioma cell lines)
-
Concentration:0.001-10 μM
-
Incubation Time:48 h
-
Result:Inhibited CTGF expression in ZL55 cells with an IC50 >1000 nM.
Inhibited CTGF expression in NCI-H226 cells with an IC50 of 826 nM and an Emax of 99%.
Inhibited CTGF expression in NCI-H2052 cells with an IC50 of 875 nM and an Emax of 89%.
Chemical Information
-
Peso molecular 870.93
-
Fòrmula C47H50F4N6O6
-
SMILES
O=C(C1=CC2=CC=CC(C3=CC=C(C(F)(F)F)C=C3)=C2N=C1)NCC4=CC=CC(OCCOC5=CC=C(F)C(NC([C@H]6N(C([C@@H](NC([C@@H](NC)C)=O)C(C)(C)C)=O)CCC6)=O)=C5)=C4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)